Cargando…
Immunomodulatory potential of anti-IFN-beta antibodies on monocyte-derived macrophages
Introduction: Multiple sclerosis (MS) is a disabling neurological disease with an unknown etiology, where the recombinant interferon beta (rIFNβ) is the most established treatment. However, the development of anti-IFNβ antibodies has posed a significant therapeutic drawback. In this study, the inter...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
HBKU Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660450/ https://www.ncbi.nlm.nih.gov/pubmed/38025317 http://dx.doi.org/10.5339/qmj.2023.sqac.13 |